Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Pain 1Neurotoxicity Syndromes 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lymphoma 1Leukemia 1

Interventions

Tacrolimus 6Busulfan 6fludarabine phosphate 4fludarabine 4Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Cyclophosphamide 4Whole-Body Irradiation 3ponatinib 2Patient Reported Outcome Measures 2Mesna 2Melphalan 2Early Intervention, Educational 2Bone Marrow Transplantation 2Antilymphocyte Serum 2Alemtuzumab 2trametinib 1ruxolitinib 1ethanolamine oleate 1dabrafenib 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Tinzaparin 1Thiotepa 1Sulfamethoxazole 1Stem Cell Transplantation 1Sodium Chloride 1Sirolimus 1Saline Solution, Hypertonic 1Saline Solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoproliferative Disorders × Baclofen × Myeloid × Clear all
NCT00516503 2017-08-24

Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
208 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoproliferative Disorders, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Pain, Neurotoxicity Syndromes, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡